Efter 16 ugers behandling, indgik patienterne, der havde opnået mindst et PASI- 75- respons (PASI- score forbedring på mindst 75% i forhold til baseline), over i periode B og modtog åben 40 mg Humira hver anden uge.
After 16 weeks of therapy, patients who achieved at least a PASI 75 response (PASI score improvement of at least 75% relative to baseline), entered period B and received open-label 40 mg Humira every other week.